High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
about
Knowledge, attitudes and practice of communities of Wolaita, Southern Ethiopia about long-lasting insecticidal nets and evaluation of net fabric integrity and insecticidal activityThe structure ofPlasmodium vivaxphosphatidylethanolamine-binding protein suggests a functional motif containing a left-handed helixDeclining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western EthiopiaLow-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, AngolaMultiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malariaEfficacies of DHA-PPQ and AS/SP in patients with uncomplicated Plasmodium falciparum malaria in an area of an unstable seasonal transmission in SudanComparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialPopulation mobility, globalization, and antimicrobial drug resistance.Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.Regulation of CD8+ T cell responses to infection with parasitic protozoa.Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.Plasmodium vivax dhfr mutations among isolates from malarious areas of IranDetection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparumMolecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.Abundance and dynamics of anopheline larvae in a highland malarious area of south-central EthiopiaChloroquine efficacy for Plasmodium vivax malaria treatment in southern EthiopiaA pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivaxPopulation genetics analysis during the elimination process of Plasmodium falciparum in Djibouti.Presumptive treatment with sulphadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anaemia in Uganda: a randomized controlled trial.High prevalence of pfcrt-CVIET haplotype in isolates from asymptomatic and symptomatic patients in south-central Oromia, Ethiopia.Prevalence of mutation and phenotypic expression associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum and Plasmodium vivax.Transmission dynamics of co-endemic Plasmodium vivax and P. falciparum in Ethiopia and prevalence of antimalarial resistant genotypes.Characterisation of pvmdr1 and pvdhfr genes associated with chemoresistance in Brazilian Plasmodium vivax isolates.Comparative genomic analysis of simple sequence repeats in three Plasmodium species.Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.
P2860
Q26315527-90FAAC7A-50B7-4F12-A3FF-6F96719A258CQ27643945-121116D5-666D-4EFB-AE1D-A8A84F858046Q28125927-53B750B5-68F5-4FFF-BD50-233DDE8948FAQ28125937-2963CD7E-C964-4D2B-87B9-FBBE99458715Q28475195-0E44AF2C-D660-4B9F-96B8-54AB8D3C5509Q33587604-B798A241-70F5-406A-B4F4-E70E6BDDF5EEQ33693625-ABEF4797-E9E0-47E8-BCE7-4D79813D0F26Q33800616-31397FD4-4152-41BA-98FD-9A0E59232187Q34068703-C3554869-832C-4D75-8CBE-FA10830C0F5DQ34108177-FA3C738F-12F8-46BC-A156-B568B9422737Q34504371-94114020-7B22-4788-9D19-6E6E5CC2D860Q35062262-2DCEE243-5B38-4530-B38C-A1DD922FD56FQ35179188-3FF25691-9444-4155-856F-D4E673E876F1Q35228689-D287D49E-9221-473D-8BE0-491A8D0FD969Q35647659-72C4F14E-D55F-48BF-ACCF-463DC6B12259Q35814367-DDC1FAB0-A316-47C6-BA82-B8F18BF520B0Q36150493-BA6F2BAD-7182-40D6-9FA1-1891A9CF0506Q36402050-9983C99E-5699-4902-B60A-08F6081A692FQ36503457-A9F984E6-A4FA-4259-946A-BEFCB0C647C8Q36937401-B492A136-4337-48B1-83DF-CD0593DE46EAQ37414298-655AF2CB-837D-474A-BAEB-777C806723C6Q37702732-2F501682-EC11-441E-A349-7C10A8775F63Q39310650-3370CB99-8473-433E-961F-FB43E733C824Q40107578-607AE02A-B0E9-4BD5-9F1D-A9022D2CB93EQ41937010-CF5ED115-D32F-4913-94CB-D6CD0FBD7090Q46281244-6EA51373-33F2-4CBF-8E26-4ACB45DA3258Q47995034-F5EFC743-891E-41F8-8A65-9645CF99E1B5
P2860
High prevalence of drug-resistance mutations in Plasmodium falciparum and Plasmodium vivax in southern Ethiopia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@ast
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@en
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@nl
type
label
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@ast
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@en
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@nl
prefLabel
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@ast
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@en
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@nl
P2093
P2860
P921
P356
P1433
P1476
High prevalence of drug-resist ...... um vivax in southern Ethiopia.
@en
P2093
Abraham Alano
Isabel Barreto Miranda
Maha E Osman
Susanne Roewer
Thomas Löscher
Ulrich Bienzle
Wondimagegn P Kumma
P2860
P2888
P356
10.1186/1475-2875-5-54
P577
2006-07-03T00:00:00Z
P5875
P6179
1030186746